We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Presents POC Critical Care Blood Gas Analyzers at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022

Nova Biomedical (Waltham, MA, USA) is presenting its range of whole blood testing products that improve patient safety and care, including point-of-care, whole blood meters and critical care blood gas analyzers, at the 2022 AACC Clinical Lab Expo. More...



At AACC 2022, Nova is highlighting the Allegro POC capillary blood chemistry analyzer that features a clinically important menu of 10 measured and individually selectable tests, plus seven calculated tests. All measured tests are analyzed using disposable, ready-to-use cartridges or test strips, and are easily performed by non-technical personnel. A very small capillary blood drop is all that is required, eliminating the need for a venipuncture or a trained phlebotomist. Allegro’s 6 - 9-minute test times - and ability to run two cartridges simultaneously - provide rapid results during the patient visit.

The company is also showcasing the Nova Max Creatinine/eGFR, a fast, accurate, and easy to use meter and biosensor for kidney function testing that reports creatinine and estimated glomerular filtration rate (eGFR) results (with or without race as a factor) using the CKD-EPI equation from a small, capillary fingerstick blood sample in just 30 seconds. The measurement technique is very easy to use and is virtually identical to the use of a glucose meter. Nova Max Pro Creatinine measuring technology is based on Nova’s StatSensor Creatinine enzymatic technology that has been proven in hospital point-of-care applications for over 15 years.

Also on display at the Nova AACC 2022 booth will be the Stat Profile Prime Plus comprehensive whole blood critical care analyzer that offers blood gases, electrolytes, metabolites, hematology, and co-oximetry testing in a simple, compact device. Prime Plus helps clinicians assess acid base balance, electrolyte balance, glycemic control, kidney function, blood oxygenation, oxygen carrying capacity of blood, tissue hypoxia, and plasma volume (ePV) in one minute from two drops of blood. The analyzer uses a small 135µL sample and supplements liquid quality controls with automated real-time electronic quality control monitoring.
 

Related Links:
Nova Biomedical


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Luteinizing Hormone Test
Luteinizing Hormone (LH) Rapid Test
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.